Evidence map›Paper›PMID 40428117›Full record

ArticleBioengineering (Basel, Switzerland)2025

Machine Learning-Based Ensemble Feature Selection and Nested Cross-Validation for miRNA Biomarker Discovery in Usher Syndrome.

Rama Krishna Thelagathoti, Dinesh S Chandel, Wesley A Tom, Chao Jiang, Gary Krzyzanowski, Appolinaire Olou, M Rohan Fernando

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rama Krishna ThelagathotiMolecular Diagnostic Research Laboratory, Center for Sensory Neuroscience, Boys Town National Research Hospital, Omaha, NE 68010, USA.ORCID 0000-0002-4986-5027
Dinesh S ChandelMolecular Diagnostic Research Laboratory, Center for Sensory Neuroscience, Boys Town National Research Hospital, Omaha, NE 68010, USA.ORCID 0000-0002-0424-9423
Wesley A TomMolecular Diagnostic Research Laboratory, Center for Sensory Neuroscience, Boys Town National Research Hospital, Omaha, NE 68010, USA.ORCID 0000-0002-5951-5311
Chao JiangMolecular Diagnostic Research Laboratory, Center for Sensory Neuroscience, Boys Town National Research Hospital, Omaha, NE 68010, USA.
Gary KrzyzanowskiMolecular Diagnostic Research Laboratory, Center for Sensory Neuroscience, Boys Town National Research Hospital, Omaha, NE 68010, USA.
Appolinaire OlouMolecular Diagnostic Research Laboratory, Center for Sensory Neuroscience, Boys Town National Research Hospital, Omaha, NE 68010, USA.
M Rohan FernandoMolecular Diagnostic Research Laboratory, Center for Sensory Neuroscience, Boys Town National Research Hospital, Omaha, NE 68010, USA.ORCID 0000-0002-3596-3160

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Usher syndrome (USH) is a rare genetic disorder affecting vision, hearing, and balance. Identifying reliable biomarkers is crucial for early diagnosis and understanding disease mechanisms. MicroRNAs (miRNAs), key regulators of gene expression, hold promise as biomarkers for USH. This study aimed to identify a minimal subset of miRNAs that could serve as biomarkers to effectively differentiate USH from controls. We employed ensemble feature selection techniques to select the top miRNAs appearing in at least three algorithms. Machine learning models were trained and tested using this subset, followed by validation on an independent 10% sample. Our approach identified 10 key miRNAs as potential biomarkers for USH. To further validate their biological relevance, we conducted pathway analysis, which revealed significant pathways associated with USH. Furthermore, our approach achieved high classification performance, with an accuracy of 97.7%, sensitivity of 98%, specificity of 92.5%, F1 score of 95.8%, and an AUC of 97.5%. These findings demonstrate that combining ensemble feature selection with machine learning provides a robust strategy for miRNA biomarker discovery, advancing USH diagnosis and molecular understanding.

Indexed as

biomarker discoveryensemble feature selectionmachine learningmiRNAnested cross-validationusher syndrome

Identifiers

PMID40428117
PMCPMC12108575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.